EquityBulls

Latest News

Keywords Selected: USMarket

Market Commentary

Stock Report

Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules for the U.S. market
Scorpius Trackers Inc. Launches in the USA, Targets 2,000 MW Annual Supply by 2028
Cosmo Films announces Launch of Seven New Films for U.S Market
STL introduces Optical Connectivity portfolio for the US market
Dr. Reddy's Laboratories announces the launch of Doxycycline Capsules, 40 mg* in the U.S.
Shilpa Medicare updates on launch of Pemetrexed Injection, 100mg/10 ml, 500 mg/50 ml, 1000 mg/100 ml
Wardwizard Foods and Beverages Ltd embarks on US Market Expansion, Secures USFDA Registration
Zydus and Synthon enter into an exclusive licensing and supply agreement for Palbociclib Tablets for the US market
Responsive Industries Introduces 'Artisan Edge'
Dr. Reddy's Laboratories announces the launch of Regadenoson Injection 0.4 mg/5 mL in the U.S.
Dr. Reddy's Laboratories announces the launch of Treprostinil Injection in the U.S.
Dr. Reddy's Laboratories launches Difluprednate Ophthalmic Emulsion 0.05% in the U.S. Market
Glenmark Pharmaceuticals Ltd updates on Baddi facility
Jet Freight to expand operations in US Market as well
Dr. Reddy's Labs launches Fesoterodine Fumarate Extended-Release Tablets in the U.S. market
NATCO announces Launch of First Generic Version of Nexavar® (Sorafenib) Tablets in the U.S. Market
Bortezomib for Injection, 3.5 mg/vial, Single-Dose Vial launched in the US Market
Lupin Launches Merzee® Capsules in the United States
izmo launches new product - izmoEmporio - in the US
BEL signs USD 73 Million contract with Hyperion Global Group LLC, USA, for supply of IoT devices to the US
Dr. Reddy's Laboratories announces the launch of Ephedrine Sulfate Injection USP, 50 mg/mL, Single-Dose Vial in the U.S. Market